Cite
Osteopontin, a Mediator of Vascular Remodeling, Correlates with Clinical Markers in PAH Patients
MLA
L Liaw, et al. “Osteopontin, a Mediator of Vascular Remodeling, Correlates with Clinical Markers in PAH Patients.” C64. DIAGNOSIS OF PULMONARY HYPERTENSION: HEMODYNAMICS AND BIOMARKERS, Apr. 2009. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........6b2a151994bf8d56c89f7a02467da857&authtype=sso&custid=ns315887.
APA
L Liaw, Tina S. Manley, Joel A. Wirth, A Ng, A Gurney, & Katherine M. Nichols. (2009). Osteopontin, a Mediator of Vascular Remodeling, Correlates with Clinical Markers in PAH Patients. C64. DIAGNOSIS OF PULMONARY HYPERTENSION: HEMODYNAMICS AND BIOMARKERS.
Chicago
L Liaw, Tina S. Manley, Joel A. Wirth, A Ng, A Gurney, and Katherine M. Nichols. 2009. “Osteopontin, a Mediator of Vascular Remodeling, Correlates with Clinical Markers in PAH Patients.” C64. DIAGNOSIS OF PULMONARY HYPERTENSION: HEMODYNAMICS AND BIOMARKERS, April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........6b2a151994bf8d56c89f7a02467da857&authtype=sso&custid=ns315887.